Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0692 EUR
−21.22 M EUR
0.00 EUR
315.01 M
About SERNOVA BIOTHERAPEUTICS INC
Sector
Industry
CEO
Jonathan M. N. Rigby
Website
Headquarters
London
Founded
1998
Sernova Corp. is a clinical-stage biotechnology company, which engages in advancing regenerative medicine in the treatment of chronic diseases. It focuses on its proprietary Cell Pouch, a bio-hybrid organ system which is designed to enhance the delivery of cell therapy to better replicate natural body functions. The company was founded on August 19, 1998 and is headquartered in London, Canada.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on LSX exchange Sernova Biotherapeutics Inc stocks are traded under the ticker A411DW.
A411DW stock has fallen by −12.24% compared to the previous week, the month change is a −12.24% fall, over the last year Sernova Biotherapeutics Inc has showed a −12.24% decrease.
We've gathered analysts' opinions on Sernova Biotherapeutics Inc future price: according to them, A411DW price has a max estimate of 4.06 EUR and a min estimate of 0.68 EUR. Watch A411DW chart and read a more detailed Sernova Biotherapeutics Inc stock forecast: see what analysts think of Sernova Biotherapeutics Inc and suggest that you do with its stocks.
A411DW stock is 41.67% volatile and has beta coefficient of −1.46. Track Sernova Biotherapeutics Inc stock price on the chart and check out the list of the most volatile stocks — is Sernova Biotherapeutics Inc there?
Yes, you can track Sernova Biotherapeutics Inc financials in yearly and quarterly reports right on TradingView.
Sernova Biotherapeutics Inc is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
A411DW earnings for the last quarter are −0.02 EUR per share, whereas the estimation was −0.02 EUR resulting in a −16.67% surprise. The estimated earnings for the next quarter are −0.03 EUR per share. See more details about Sernova Biotherapeutics Inc earnings.
Sernova Biotherapeutics Inc revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
A411DW net income for the last quarter is −3.28 M EUR, while the quarter before that showed −5.04 M EUR of net income which accounts for 35.04% change. Track more Sernova Biotherapeutics Inc financial stats to get the full picture.
No, A411DW doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 15, 2025, the company has 17.00 employees. See our rating of the largest employees — is Sernova Biotherapeutics Inc on this list?
Like other stocks, A411DW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sernova Biotherapeutics Inc stock right from TradingView charts — choose your broker and connect to your account.